About Us
Areas of Focus
Products
Partnering
News
Careers

Terms and Conditions of Use
Privacy Policy

About Us
Areas of Focus
Products
Partnering
News
Careers

fr

PENDOPHARM AND YOU:

Growing Together

Visit our parent company Pharmascience careers website to explore available positions.

VISIT THE CAREERS WEBSITE

News

Welcome to our newsroom – get the latest news and updates from Pendopharm.

All publications

Posted on September 2, 2026

Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism

Posted on July 27, 2026

Cingal® Marks Its 10th Anniversary and International Recognition

Posted on February 27, 2026

Pendopharm announces the commercialization of Buccolam® in Canada

Posted on February 6, 2026

Pendopharm Announces the Approval of Yorvipath® (palopegteriparatide injection) for the Treatment of Chronic Hypoparathyroidism in Adults.

Posted on August 4, 2025

Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for T\CBuccolam® in Canada and announces its authorization by Health Canada.

1
2
3
4
5
6
7
→

Publications

All
Award / Recognition
Business News
Employer awards
News
Partnership
Press releases
Product Launch
Product Update

Media Relations

Please send us an email and provide us with your contact information as well as the name of your media/publication/source. A member of our team will contact you back quickly.

If you are not a member of the media, please see additional contact information on our Contact Us page

© 2026 Pendopharm. All rights reserved

Terms and Conditions of Use
Privacy Policy